AI
EW icon

AXS Investments’s Edwards Lifesciences EW Stock Holding History

AXS Investments’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$93.8K Sell
1,037
-246
-19% -$20.6K 0.03% 139
2026
Q1 		$103K Sell
1,283
-241
-16% -$19.9K 0.04% 134
2025
Q4 		$130K Sell
1,524
-238
-14% -$19.5K 0.04% 141
2025
Q3 		$137K Buy
+1,762
New +$138K 0.04% 141
2024
Q1 		– Sell
-1,774
Closed -$135K – 340
2023
Q4 		$135K Sell
1,774
-1,175
-40% -$81.8K 0.03% 317
2023
Q3 		$204K Sell
2,949
-13,991
-83% -$1.12M 0.05% 261
2023
Q2 		$1.6M Buy
16,940
+14,778
+684% +$1.28M 0.43% 59
2023
Q1 		$179K Sell
2,162
-14,961
-87% -$1.18M 0.06% 218
2022
Q4 		$1.28M Buy
17,123
+14,701
+607% +$1.13M 0.46% 62
2022
Q3 		$200K Sell
2,422
-468
-16% -$45K 0.08% 201
2022
Q2 		$275K Sell
2,890
-1,056
-27% -$109K 0.1% 191
2022
Q1 		$465K Sell
3,946
-1,551
-28% -$174K 0.19% 88
2021
Q4 		$712K Buy
+5,497
New +$641K 0.17% 97
2021
Q3 		– Sell
-9,674
Closed -$1M – 144
2021
Q2 		$1M Buy
9,674
+2,121
+28% +$200K 0.31% 77
2021
Q1 		$632K Buy
+7,553
New +$639K 0.22% 90

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

AXS Investments's EW Position: Q2 2026 in Review

AXS Investments reduced its Edwards Lifesciences (EW) stake by 19% in Q2 2026, selling an estimated $20.6K and leaving 1,037 shares worth $93.8K. The position accounts for 0.03% of the portfolio, ranked #139.

AXS Investments first reported a position in EW in Q1 2021 and has held it in 15 quarters since. The position peaked at $1.6M in Q2 2023. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • AXS Investments held 1,037 shares of Edwards Lifesciences worth $93.8K as of Q2 2026.
  • AXS Investments sold 246 Edwards Lifesciences shares in Q2 2026, an estimated $20.6K.
  • Edwards Lifesciences made up 0.03% of AXS Investments's portfolio in Q2 2026, its #139 holding.
  • AXS Investments first reported a position in Edwards Lifesciences in Q1 2021 and has held it in 15 quarters since.
  • AXS Investments's Edwards Lifesciences position peaked at $1.6M in Q2 2023.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on AXS Investments's 13F filing for Q2 2026, filed 10 Aug 2026.